IonQ, Inc. filings document a public quantum technology company with common stock, warrants and recurring capital-structure disclosures. Its 8-K reports include operating and financial results, material-event updates, registration rights agreements, unregistered equity issuances, resale prospectus supplements and acquisition-related share issuances, including the completed Skyloom Global acquisition.
IonQ proxy materials cover shareholder voting matters, board governance, executive compensation and pay-versus-performance disclosures. The company’s filing record also reflects material agreements, warrant and common-stock terms, financial reporting furnished with earnings releases, and governance matters connected to its quantum computing, networking, sensing, security and space-based data businesses.
IonQ, Inc. director and President & CEO Niccolo de Masi reported the sale of 16,120 shares of IonQ common stock on 09/11/2025. The filing states these sales were executed as a sell-to-cover to satisfy statutory tax withholding obligations upon vesting of restricted stock units, not as discretionary open-market dispositions. The weighted-average price for the shares sold is reported as $44.4016, with individual trade prices ranging from $43.41 to $45.505. After the transaction, de Masi beneficially owns 1,181,186 shares, held directly.
IonQ, Inc. insider filing reports a proposed sale of 129,670 common shares through Morgan Stanley on 09/12/2025, with an aggregate market value of $6,100,973.50. The shares were originally acquired on 02/24/2021 from the issuer by exercise of stock options, paid in cash. The filing lists total outstanding shares of 296,837,796, and discloses that the same account sold 461,214 shares under 10b5-1 plans during the prior three months, generating gross proceeds of $19,044,783.58. The filer certifies there is no undisclosed material adverse information and references Rule 10b5-1 plan usage.
IonQ Form 144 filing summary
The filing notifies a proposed sale of 8,773 shares of IonQ common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $412,769.65. The shares represent a portion of the issuer's reported 296,837,796 outstanding shares. The filer acquired the shares on 09/12/2025 by exercising stock options and paid cash on the same date. The filer reports no securities sold in the past three months for the account. The notice includes the standard representation that the selling person is not aware of undisclosed material adverse information.
IonQ, Inc. Form 144 discloses a proposed sale of 20,470 shares of common stock, to be brokered through E-TRADE on 09/11/2025, with an aggregate market value of $900,680.00. The filing shows these shares were acquired on 09/10/2025 upon vesting of restricted stock units and were granted as equity compensation by the issuer. The filing also reports a prior sale by Niccolo de Masi of 2,597,500 shares on 06/11/2025, yielding gross proceeds of $104,793,280.25. The filer certifies no undisclosed material adverse information and includes the standard attestation regarding criminal penalties for misstatement.
Form 144 notice for IonQ, Inc. (IONQ): The filing reports a proposed sale of 5,120 shares of common stock, acquired on 09/10/2025 upon vesting of restricted stock units. The shares have an aggregate market value of $225,280 and the sale is scheduled approximately for 09/11/2025 through E-TRADE Financial Corporation on the NYSE. The issuer outstanding share count shown is 297,682,418. The filer states there were no securities sold in the past three months for the account and affirms no undisclosed material adverse information is known. The document provides transaction timing, acquisition method (RSU vesting), broker, and market value but does not identify the selling person by name in the provided text.
Form 144 filed for IonQ, Inc. (IONQ) reports a proposed sale of 25,370 shares of common stock through E-TRADE with an aggregate market value of $1,116,280 and an approximate sale date of 09/11/2025. The shares were acquired on 09/10/2025 upon vesting of restricted stock units and payment was made as equity compensation on the same date. The filer discloses recent insider sales: 45,000 shares on 07/07/2025 for $2,078,100, 65,000 shares on 06/13/2025 for $2,506,757.50, and 19,976 shares on 06/11/2025 for $830,909.71. The notice includes the standard signature representation that the seller is unaware of undisclosed material adverse information.
Insider award disclosure: This Form 4 reports that Inder M. Singh, identified as CFO and COO of IonQ, Inc. (IONQ), was granted 160,294 restricted stock units (RSUs) on 09/04/2025 at no cash price recorded ($0). After the award, the reporting person beneficially owned 165,807 shares of IonQ common stock. The RSUs vest over four years: 25% on September 10, 2026 and then quarterly on December 10, March 10, June 10 and September 10 thereafter, subject to continued service.
The filing was signed by an attorney-in-fact on 09/08/2025. The Form 4 shows a non-derivative acquisition via an equity award and discloses the vesting schedule but does not report any exercised options, cash purchases, or sales.
IonQ CFO Thomas G. Kramer reported the sale of 64,578 shares of IonQ common stock on 09/03/2025 under a pre-established Rule 10b5-1 trading plan adopted March 14, 2025. The shares were sold at a weighted average price of $41.8232, with individual sale prices ranging from $40.59 to $42.98, and the reporting person retains beneficial ownership of 473,302 shares directly plus 5 shares indirectly through a child. The Form 4 was signed by an attorney-in-fact on 09/05/2025.
IonQ, Inc. reported an executive transition, appointing Lead Independent Director Inder M. Singh as Chief Financial Officer and Chief Operating Officer effective September 4, 2025, succeeding CFO Thomas Kramer. In connection with his new roles, Mr. Singh has stepped down from the board.
Under his offer letter, Mr. Singh will receive a $500,000 annual base salary and is eligible for an annual cash bonus targeted at 100% of salary, with a prorated 2025 bonus based on the transition date. He will be granted initial equity awards consisting of RSUs valued at $6,750,000, performance-based RSUs with a target value of $18,000,000 (with an opportunity to vest in up to 200% of that target) over a three-year performance period covering calendar years 2025–2027, and an additional make-whole RSU award equal to forfeited contingent compensation, vesting on the second anniversary of the transition date.
Mr. Singh will be eligible for severance benefits under IonQ’s Amended and Restated Executive Severance Plan in the event of a covered termination, including continued salary and target bonus for 9–12 months depending on whether a change in control is involved, a pro-rata target bonus for the year of termination, COBRA subsidies aligned with the severance period, and acceleration of certain equity awards. A press release announcing the transition is filed as an exhibit.
Form 144 notice reports a proposed sale of 158,330 shares of common stock of the issuer through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $6,806,606.70. The shares were acquired on 02/24/2021 via previously exercised stock options and payment was recorded the same day. The filing lists prior sales by the same account in the past three months totaling 406,630 shares for $16,759,629.40. The notice includes the standard Rule 144 representation and references reliance on 10b5-1 sales in several prior transactions.